{
    "clinical_study": {
        "@rank": "10084", 
        "arm_group": {
            "arm_group_label": "Femoral block, ultrasound, bupivacaine", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine the minimum effective concentration of bupivacaine\n      (EC50) in femoral block for analgesia by ultrasound after knee surgery."
        }, 
        "brief_title": "Evaluation of the Minimum Effective Concentration of Bupivacaine (EC50) in Femoral Block for Analgesia by Ultrasound After Knee Surgery", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Knee Surgery", 
            "Postoperative Pain"
        ], 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "45 patients classified as ASA P1 or P2 aged between 18 and 65 candidates for elective knee\n      operation via arthroscopy were included in the study. All patients received femoral nerve\n      block guided by ultrasound with bupivacaine, 22 ml. The first patient at a concentration of\n      0.25%. The other patients with higher or lower concentrations if the first patient has pain>\n      3 or <3 on visual analogic scale respectively after awakening of surgical anesthesia. For\n      surgical anesthesia each patient will undergo general anesthesia. At the end of the surgical\n      procedure and anesthetic awakening patients will be evaluated for analgesia by verbal\n      numeric scale. The modified Dixon method was used to find the EC50 and EC95 of bupivacaine\n      for analgesia of femoral nerve block guided by ultrasound. Concentration still correlated\n      with motor block and side effects."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients to undergo knee surgery\n\n        Exclusion Criteria:\n\n          -  patients with coagulopathy\n\n          -  pregnant\n\n          -  infection at the puncture site\n\n          -  chronic pain"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02124005", 
            "org_study_id": "EC50 femoral block bupivacaine"
        }, 
        "intervention": {
            "arm_group_label": "Femoral block, ultrasound, bupivacaine", 
            "intervention_name": "Bupivacaine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Bupivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Knee surgery", 
            "Femoral block", 
            "Bupivacaine", 
            "Ultrasound"
        ], 
        "lastchanged_date": "April 24, 2014", 
        "location": {
            "contact": {
                "email": "edcrmoura@yahoo.com.br", 
                "last_name": "Ed Carlos Moura, research", 
                "phone": "559884046958"
            }, 
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "state": "SP", 
                    "zip": "04023-061"
                }, 
                "name": "Universidade Federal de S\u00e3o Paulo"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of the Minimum Effective Concentration of Bupivacaine (EC50) in Femoral Block for Analgesia by Ultrasound After Knee Surgery", 
        "overall_contact": {
            "email": "edcrmoura@yahoo.com.br", 
            "last_name": "Ed Carlos Moura, research", 
            "phone": "559884046958"
        }, 
        "overall_official": {
            "affiliation": "Federal University of S\u00e3o Paulo", 
            "last_name": "Ed Carlos Moura, research", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "45 patients classified as ASA P1 or P2 aged between 18 and 65 candidates for elective knee operation via arthroscopy were included in the study. All patients received femoral nerve block guided by ultrasound with bupivacaine, 22 ml. The first patient at a concentration of 0.25%. The other patients with higher or lower concentrations if the first patient has pain> 3 or <3 on visual analogic scale respectively after awakening of surgical anesthesia. For surgical anesthesia each patient will undergo general anesthesia. At the end of the surgical procedure and anesthetic awakening patients will be evaluated for analgesia by verbal numeric scale. The modified Dixon method was used to find the EC50 and EC95 of bupivacaine for analgesia of femoral nerve block guided by ultrasound. Concentration still correlated with motor block and side effects.", 
            "measure": "Pain Scores on the Visual Analog Scale", 
            "safety_issue": "Yes", 
            "time_frame": "two years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02124005"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of S\u00e3o Paulo", 
            "investigator_full_name": "Ed Carlos Rey Moura", 
            "investigator_title": "doctor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Federal University of S\u00e3o Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ed Carlos Rey Moura", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}